Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 247,380 | 193,780 | 119,150 | 101,200 | 28,270 |
| Cost of Goods | 156,360 | 111,770 | 70,200 | 77,440 | 19,340 |
| Gross Profit | 91,020 | 82,010 | 48,940 | 23,760 | 8,930 |
| Operating Expenses | 77,590 | 69,610 | 60,230 | 44,750 | 24,590 |
| Operating Income | 13,790 | 13,170 | -11,080 | -20,550 | -15,320 |
| Interest Expense | 9,780 | 6,780 | 3,460 | 520 | 550 |
| Other Income | 1,950 | 1,450 | 1,270 | 2,880 | 6,290 |
| Pre-tax Income | 5,960 | 7,840 | -13,270 | -18,190 | -9,580 |
| Income Tax | 7,330 | 6,880 | 4,240 | 4,420 | -3,060 |
| Net Income Continuous | -8,429 | -4,444 | -20,153 | -16,431 | -2,240 |
| Net Income | $10,570 | $-4,780 | $-20,150 | $-25,780 | $-2,240 |
| EPS Basic Total Ops | 13,797.20 | -5,998.80 | -28,194.40 | -25,794.80 | N/A |
| EPS Basic Continuous Ops | -10,536.25 | -5,555.00 | -28,790.00 | -27,385.00 | N/A |
| EPS Diluted Total Ops | 13,197.40 | -5,998.80 | -28,194.40 | -25,794.80 | N/A |
| EPS Diluted Continuous Ops | -10,536.25 | -5,555.00 | -28,790.00 | -27,385.00 | N/A |
| EBITDA(a) | $21,390 | $20,620 | $-4,340 | $-18,130 | $-14,130 |